The global smallpox treatment market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Smallpox is a deadly disease caused by infection with the variola virus. It is a contagious, disfiguring disease and is transmitted from person to person. The therapeutic regimen to treat smallpox involves supportive care, which uses vaccines as an anti-viral drug and preventive measure.
The growing awareness regarding the smallpox vaccines and benefits from the government initiatives such as awareness programs, vaccination programs among others are the major factors that are expected to fuel the growth of the global smallpox treatment market during the forecast period. Moreover, the development of smallpox immunization techniques and their global administration is also anticipated to boost the demand of the global smallpox treatment market. Additionally, increasing research and development for novel therapies for smallpox is to further extend suitable opportunities for the growth of the market during the forecast period. The global smallpox treatment market analysis includes some of the key market players such as SIGA Technologies, Bavarian Nordic, EpiVax, Inc., CEL-SCI, Chimerix, Nano Therapeutics, Pvt Ltd, and Oncovir, Inc., among others.
Market Coverage
Competitive Landscape: SIGA Technologies, Bavarian Nordic, EpiVax, Inc., CEL-SCI, Chimerix, Nano Therapeutics, Pvt Ltd, and Oncovir, Inc., among others.
Key questions addressed by the report
o Recovery Timeline
o Deviation from pre-COVID forecast
o Most affected region and segment
Global Smallpox Treatment Market by Segment
By Type
• Ordinary Smallpox (Variola Major
• Sequelae
• Modified-Type Smallpox
• Others
By Treatment Type
• Medication
• Vaccination
• Others
By Route Of Administration
• Oral
• Injectable
• Others
By End-Users
• Hospitals
• Homecare
• Specialty Clinics
• Others
Global Smallpox Treatment Market by Regional Analysis
North America
Europe
Asia-Pacific
Rest of the World